Re:How Meadow Is Building a Company and Community Around Can...
by auntienomen on Friday April 08, 2016 @10:28AM
(#11454838)
It's very difficult to do clinical research on schedule 1 drugs. You need a DEA license, and FDA approval. Lots of hoop jumping, lots of opportunity for prohibitionists to forbid the research.
Moving marijuana to schedule 2 will allow scientists to make honest assessments of its benefits and harms.
How would a reduced federal scheduling level for cannabis also reduce the state's power?